Company Filing History:
Years Active: 2014-2016
Title: Zeni Alfonso: Innovator in Lymphatic System Treatments
Introduction
Zeni Alfonso is a notable inventor based in Temecula, California, recognized for her contributions to medical innovations. She holds two patents that focus on the treatment of the lymphatic system and malignant diseases. Her work is pivotal in advancing therapeutic methods that utilize adipose tissue-derived cells.
Latest Patents
Zeni Alfonso's latest patents include methods for using adipose tissue-derived cells in the treatment of the lymphatic system and malignant diseases. These inventions provide methods for preparing and utilizing adipose-tissue-derived stem and progenitor cells, as well as lymphatic endothelial cells. The patents detail how these cells can be used to treat disorders of the lymphatic system and to promote its expansion, repair, and regeneration. Furthermore, her inventions explore the use of these cells for delivering therapeutic agents to tumor cells, offering new avenues for treating malignant diseases. Assays to screen for drugs that can modulate lymphatic system functions are also included in her patents.
Career Highlights
Zeni Alfonso is currently associated with Cytori Therapeutics, Inc., where she continues to innovate in the field of regenerative medicine. Her work has significant implications for improving treatment options for patients with lymphatic disorders and cancers.
Collaborations
Zeni collaborates with John K. Fraser, who is also involved in advancing research in related fields. Their partnership enhances the potential for groundbreaking discoveries in medical treatments.
Conclusion
Zeni Alfonso's contributions to the field of medical innovation, particularly in the treatment of the lymphatic system and malignant diseases, underscore her role as a leading inventor. Her patents reflect a commitment to improving patient outcomes through advanced therapeutic methods.